Greenwood Capital Associates’s Clorox CLX Stock Holding History

Greenwood Capital Associates’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,493	Closed	-$851K	–	249
2023 Q3	$851K	Buy	+6,493	New	+$987K	0.12%	151

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Greenwood Capital Associates's CLX Position: Q4 2023 in Review

Greenwood Capital Associates sold out of Clorox (CLX) in Q4 2023, closing a stake of 6,493 shares — an estimated $851K sold.

Greenwood Capital Associates first reported a position in CLX in Q3 2023 and held it in 1 quarter. The position peaked at $851K in Q3 2023. 1,107 funds tracked by Wall St. Rank hold CLX as of Q4 2023.

Greenwood Capital Associates reported no remaining Clorox position as of Q4 2023 after selling out during the quarter.
Greenwood Capital Associates sold 6,493 Clorox shares in Q4 2023, an estimated $851K.
Greenwood Capital Associates first reported a position in Clorox in Q3 2023 and held it in 1 quarter.
Greenwood Capital Associates's Clorox position peaked at $851K in Q3 2023.
1,107 funds tracked by Wall St. Rank held Clorox as of Q4 2023.

Based on Greenwood Capital Associates's 13F filing for Q4 2023, filed 5 Mar 2024.